Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens.
about
Novel approaches to identify protective malaria vaccine candidatesMalaria vaccines: identifying Plasmodium falciparum liver-stage targetsPaths to a malaria vaccine illuminated by parasite genomicsDiscovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine DevelopmentInterrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based ProteomicsExploration of panviral proteome: high-throughput cloning and functional implications in virus-host interactionsAn immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areasImmunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidateMining, visualizing and comparing multidimensional biomolecular data using the Genomics Data Miner (GMine) Web-Server.Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.Discovery of novel Schistosoma japonicum antigens using a targeted protein microarray approach.Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum.A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate.Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria.Sex-partitioning of the Plasmodium falciparum stage V gametocyte proteome provides insight into falciparum-specific cell biologyImmunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malariaAntibody and B cell responses to Plasmodium sporozoites.Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization.Proteomic features predict seroreactivity against leptospiral antigens in leptospirosis patientsA library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins.The case for a rational genome-based vaccine against malaria.Identification of seroreactive proteins of Leptospira interrogans serovar copenhageni using a high-density protein microarray approach.Protein microarray analysis of antibody responses to Plasmodium falciparum in western Kenyan highland sites with differing transmission levelsProtection of Malian children from clinical malaria is associated with recognition of multiple antigens.Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoitesSeroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria.RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites.Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunizationNew antigens for a multicomponent blood-stage malaria vaccineGenome-level determination of Plasmodium falciparum blood-stage targets of malarial clinical immunity in the Peruvian AmazonOf monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates.The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic areaA Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein InteractionsEvaluation of quantum dot immunofluorescence and a digital CMOS imaging system as an alternative to conventional organic fluorescence dyes and laser scanning for quantifying protein microarrays.Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communitiesAntibody Profiling in Naïve and Semi-immune Individuals Experimentally Challenged with Plasmodium vivax SporozoitesGenetic Resistance to Malaria Is Associated With Greater Enhancement of Immunoglobulin (Ig)M Than IgG Responses to a Broad Array of Plasmodium falciparum Antigens.Biosignatures of Exposure/Transmission and ImmunityExperimental Immunization Based on Plasmodium Antigens Isolated by Antibody Affinity.Plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally acquired humoral responses
P2860
Q21131082-29DC434E-8BD9-4183-BDFD-98C1B1F23C68Q26781372-6495CDC2-4324-438B-AE82-FFCE078D3FFFQ26853267-6872539C-D4AB-4008-BC4D-A8957AB9F7BCQ27972709-DC1D73FF-69F8-4F26-B0C1-EA6B70E7549AQ27973871-2BB6DBBE-B5B3-4767-BCDA-E2DCDFB834F0Q28116349-57948223-2C4F-4A5E-AECF-115A7846D12EQ28541675-41855D4A-F5BF-436E-B1AE-9CC8608EEA4EQ30047043-B70E065F-B078-4689-8EA7-310DCA7D26F1Q31147151-CFF2B1A0-A579-4CBA-B441-772BC68BBEA9Q33821137-51DA2331-8FFF-4247-94D6-B4AFC79E220DQ33842804-F8B8140A-C458-43A2-93EE-DB2E3AE4F351Q33960093-ECC10874-60D5-41D8-B85C-D53D57D0F12CQ34232909-39AA023D-153C-42AE-8BC3-4848B4B40A46Q34303373-3880E554-D3C0-433B-9C08-4912E2FA173EQ34303401-F41DEB5A-50CC-4EC9-951A-214186FAEB97Q34440997-0E377B6C-1ECF-447B-B102-DA5A9D820149Q34530938-A4E0D9E3-87F6-4C77-AD68-F3C12ACE50A8Q34563555-FB354F70-8357-43F9-994C-FE1379E94931Q34855317-37A2AA87-C3A4-4A7F-AFAD-BF1AB18DC250Q34991300-5984B664-1784-4DAF-BA48-452E5E64D698Q34999392-BBFBDEAB-D6CB-4DD7-AF3C-D897D24C8360Q35023683-961FDFCF-8FB1-45DE-983D-71C9E6B48CABQ35061507-322E9736-7F5D-4823-832E-8C436407DB79Q35094826-EAB94922-DE3A-4413-BB5E-FE1B73E4C08EQ35111844-6AD19FA7-F1D0-48B6-9925-BBC93AAB7E65Q35140646-8318DA5A-3CBB-4F51-8CCD-87D97F627A56Q35148353-37DDF95C-AB9F-42AC-9D74-F7BEB0E2962CQ35211003-2B4C02BE-0C9E-4548-B7B2-5FFADD17D148Q35216634-BE9FAD94-CE3F-4C1E-9189-DF84B6F63ACAQ35473530-705BF483-A6B6-43E7-A045-CF4CE9DD0A3EQ35569944-90DE2A16-6A82-48EE-A4FB-36EB31C92210Q35579613-CDF3722E-0C06-40CA-9BCB-D178EE6E2534Q35877857-ED40C190-C337-490F-883B-7C31B2A6AA1CQ35913807-AC4CC985-E538-4D82-9C34-3564BB472C3EQ35961275-D13368DA-E922-45CD-89D7-F802644FDEECQ35970236-32971A43-2975-45D7-86B9-D7A95A10DE97Q36042702-025FAC4D-D383-4D24-9CA7-95B7D51B3FCCQ36071335-E9A3B5E9-FBCC-4C21-B9A2-F7D08C32EE4AQ36204459-EFB3C994-6F00-4DC2-80C4-F454894AE643Q36213254-25A38EAE-AB6E-4BB6-B008-5A4C18D5C170
P2860
Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Sterile protective immunity to ...... novel P. falciparum antigens.
@ast
Sterile protective immunity to ...... novel P. falciparum antigens.
@en
type
label
Sterile protective immunity to ...... novel P. falciparum antigens.
@ast
Sterile protective immunity to ...... novel P. falciparum antigens.
@en
prefLabel
Sterile protective immunity to ...... novel P. falciparum antigens.
@ast
Sterile protective immunity to ...... novel P. falciparum antigens.
@en
P2093
P2860
P356
P1476
Sterile protective immunity to ...... novel P. falciparum antigens.
@en
P2093
Angela Trieu
Daniel A Freilich
Denise L Doolan
Douglas M Molina
Matthew A Kayala
Philip L Felgner
Pierre Baldi
P2860
P304
M111.007948
P356
10.1074/MCP.M111.007948
P577
2011-05-31T00:00:00Z